Skip to main content
Premium Trial:

Request an Annual Quote

Waters Offers US Water Authorities Complimentary Test

NEW YORK (GenomeWeb News) – Waters today said that it would offer water authorities in the US a complimentary drinking water analysis for common over-the-counter and prescription antidepressant pharmaceuticals.
 
The Milford, Mass.-based firm said that the “limited time” offer would be available to any US water authority that serves more than 100,000 customers. Such authorities can submit a request to the company to perform the analysis on tap water. Waters did not disclose the length of the limited time offer.
 
Waters said it would test the samples using its AquaAnalysis System.
 
Waters’ offer comes a week after the Associated Press reported the findings of its own investigation into the water supplies of 24 major metropolitan areas across the country, which found traces of a variety of drugs including antidepressants in the water.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.